Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 391

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging

Open access
Chang, Ken, Bai, Harrison X., Zhou, Hao, Su, Chang, Bi, Wenya Linda, Agbodza, Ena, Kavouridis, Vasileios K., Senders, Joeky T., Boaro, Alessandro, Beers, Andrew, Zhang, Biqi, Capellini, Alexandra, Liao, Weihua, Shen, Qin, Li, Xuejun, Xiao, Bo, Cryan, Jane, Ramkissoon, Shakti, Ramkissoon, Lori, Ligon, Keith, Wen, Patrick Y., Bindra, Ranjit S., Woo, John, Arnaout, Omar, Gerstner, Elizabeth R., Zhang, Paul J., Rosen, Bruce R., Yang, Li, Huang, Raymond Y., Kalpathy-Cramer, Jayashree·2018·Clinical Cancer Research

Abstract

Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival and may guide treatment decision making. We aimed to predict the IDH status of gliomas from MR imaging by applying a residual convolutional neural network to preoperative radiographic data. Experimental Design: Preoperative imaging was acquired for 201 patients from the Hospital of University of Pennsylvania (HUP), 157 patients from Brigham and Women's Hospital (BWH), and 138 patients from The Cancer Imaging Archive (TCIA) and divided into training, validation, and testing sets. We trained a residual convolutional neural network for each MR sequence (FLAIR, T2, T1 precontrast, and T1 postcontrast) and built a predictive model from the outputs. To increase the size of the training set and prevent overfitting, we augmented the training set images by introducing random rotations, translations, flips, shearing, and zooming. Results: With our neural network model, we achieved IDH prediction accuracies of 82.8% (AUC = 0.90), 83.0% (AUC = 0.93), and 85.7% (AUC = 0.94) within training, validation, and testing sets, respectively. When age at diagnosis was incorporated into the model, the training, validation, and testing accuracies increased to 87.3% (AUC = 0.93), 87.6% (AUC = 0.95), and 89.1% (AUC = 0.95), respectively. Conclusions: We developed a deep learning technique to noninvasively predict IDH genotype in grade II–IV glioma using conventional MR imaging using a multi-institutional data set. Clin Cancer Res; 24(5); 1073–81. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-17-2236

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 391

Metadata

Authors
Chang, K., Bai, H. X., Zhou, H., Su, C., Bi, W. L., Agbodza, E., Kavouridis, V. K., Senders, J. T., Boaro, A., Beers, A., Zhang, B., Capellini, A., Liao, W., Shen, Q., Li, X., Xiao, B., Cryan, J., Ramkissoon, S., Ramkissoon, L., Ligon, K., Wen, P. Y., Bindra, R. S., Woo, J., Arnaout, O., Gerstner, E. R., Zhang, P. J., Rosen, B. R., Yang, L., Huang, R. Y., & Kalpathy-Cramer, J.
Venue
Clinical Cancer Research
Published
2018-02-28
Volume
24
Issue
5
Pages
1073-1081
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2770261599
Cited by
391
References
51
FWCI
25.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-17-2236
The paper
Chang, K., Bai, H. X., Zhou, H., Su, C., Bi, W. L., Agbodza, E., Kavouridis, V. K., Senders, J. T., Boaro, A., Beers, A., Zhang, B., Capellini, A., Liao, W., Shen, Q., Li, X., Xiao, B., Cryan, J., Ramkissoon, S., Ramkissoon, L., . . . Kalpathy-Cramer, J. (2018). Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-17-2236

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.